Showing results (41-50 of 63) with videos related to
Sort By:
Pageof 7
Gynecologic Oncology|September 20, 2020
Impact of antibiotic treatment during platinum chemotherapy on survival and recurrence in women with advanced epithelial ovarian cancerLaura M Chambers, Michelle Kuznicki, Meng Yao, et al.Gynecologic Oncology|April 23, 2013
Radiochemotherapy plus 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, NSC #663249) in advanced-stage cervical and vaginal cancersCharles A Kunos, Tomas Radivoyevitch, Steven Waggoner, et al.Gynecologic Oncology Reports|April 8, 2022
Assessment of travel distance for hyperthermic intraperitoneal chemotherapy in women with ovarian cancerLaura M Chambers, Meng Yao, Molly Morton, et al.Gynecologic Oncology|October 15, 2023
Safety and efficacy of topical artesunate for the treatment of vulvar intraepithelial neoplasia 2/3Chad M Michener, Stephanie Ricci, Mariam AlHilli, et al.Gynecologic Oncology|July 12, 2021
Anastomotic leak following interval debulking surgery with or without hyperthermic intraperitoneal chemotherapy in women with advanced epithelial ovarian CancerMorgan Gruner, Laura M Chambers, Meng Yao, et al.Gynecologic Oncology|January 20, 2021
Impact of intra-operative factors upon peri-operative outcomes in women undergoing hyperthermic intraperitoneal chemotherapy for gynecologic cancerAnna Chichura, Laura M Chambers, Anthony B Costales, et al.Gynecologic Oncology|February 8, 2021
Patterns of recurrence in women with advanced and recurrent epithelial ovarian cancer treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapyLaura M Chambers, Meng Yao, Molly Morton, et al.Gynecologic Oncology|October 17, 2020
Assessing feasibility and perioperative outcomes with minimally invasive surgery compared with laparotomy for interval debulking surgery with hyperthermic intraperitoneal chemotherapy for advanced epithelial ovarian cancerMolly Morton, Laura M Chambers, Anthony B Costales, et al.Obstetrics and Gynecology|August 3, 2023
Association of Clinical Trial Participation With Improved Overall Survival for Recurrent, Platinum-Resistant Ovarian CancerMolly Morton, Meng Yao, Julia Chalif, et al.International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 19, 2021
Perioperative outcomes of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy in elderly women with epithelial ovarian cancer: analysis of a prospective registryLaura M Chambers, Meng Yao, Molly Morton, et al.Pageof 7